EGF Theramed Health Corp.
TMED
CNSX
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 78.22% | -71.19% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 78.22% | -71.19% | |||
| Operating Income | -78.22% | 71.19% | |||
| Income Before Tax | -16.40% | 97.02% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -16.40% | 97.87% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -79.31% | 363.64% | |||
| Net Income | -39.66% | 98.29% | |||
| EBIT | -78.22% | 71.19% | |||
| EBITDA | -- | -- | |||
| EPS Basic | -38.71% | 98.28% | |||
| Normalized Basic EPS | -62.50% | 98.07% | |||
| EPS Diluted | -38.71% | 98.28% | |||
| Normalized Diluted EPS | -62.50% | 98.07% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||